We are live on
!
Find out more
FTCM
First Trust Capital Management Portfolio holdings
AUM
$1.9B
1-Year Est. Return
58.39%
This Fund
S&P 500
This Quarter
Est. Return
+5.37%
1 Year Est. Return
+58.39%
3 Year Est. Return
+186.4%
5 Year Est. Return
+380.2%
10 Year Est. Return
–
AUM
$1.48B
AUM Growth
+$95.6M
(+6.9%)
Cap. Flow
+$45M
Cap. Flow
% of AUM
3.04%
Top 10 Holdings %
Top 10 Hldgs %
42.57%
Holding
149
New
58
Increased
19
Reduced
20
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$86.5M |
| 2 |
SKX
Skechers
SKX
|
+$81.4M |
| 3 |
DNB
Dun & Bradstreet
DNB
|
+$77.7M |
| 4 |
ESGR
Enstar Group
ESGR
|
+$58M |
| 5 |
AZEK
The AZEK Co
AZEK
|
+$51.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$94.9M |
| 2 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$82.3M |
| 3 |
PYCR
Paycor HCM, Inc. Common Stock
PYCR
|
+$77.5M |
| 4 |
JWN
Nordstrom
JWN
|
+$58.1M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 59.76% |
| 2 | Healthcare | 10.38% |
| 3 | Consumer Discretionary | 6.71% |
| 4 | Technology | 6.67% |
| 5 | Industrials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNB
1
DELISTED
Dun & Bradstreet
DNB
| $97M | 6.56% |
10,667,515
+8,677,153
| +436% | +$77.7M |
|
|
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
| $91.3M | 6.18% |
+1,943,767
| New | +$86.5M |
|
|
SKX
3
DELISTED
Skechers
SKX
| $89.5M | 6.05% |
+1,418,242
| New | +$81.4M |
|
|
K
4
DELISTED
Kellanova
K
| $72.6M | 4.91% |
912,530
-105,500
| -10% | -$8.62M |
|
|
ESGR
5
DELISTED
Enstar Group
ESGR
| $64.1M | 4.33% |
190,436
+173,522
| +1,026% | +$58M |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $58.5M | 3.95% |
+456,068
| New | +$47.4M |
|
|
AZEK
7
DELISTED
The AZEK Co
AZEK
| $56.1M | 3.79% |
+1,032,102
| New | +$51.7M |
|
|
AVDX
8
DELISTED
AvidXchange
AVDX
| $35.7M | 2.41% |
+3,643,918
| New | +$32.9M |
|
|
ANSC
9
Agriculture & Natural Solutions Acquisition Corp
ANSC
$476M
| $33.8M | 2.29% |
3,117,578
| – | – |
|
|
AAM
10
DELISTED
AA Mission Acquisition Corp
AAM
| $31.1M | 2.1% |
2,984,542
+40,000
| +1% | +$414K |
|
|
KDK
11
Kodiak AI
KDK
$802M
| $29.5M | 1.99% |
2,604,010
+664,010
| +34% | +$7.49M |
|
|
ALF
12
Centurion Acquisition Corp
ALF
| $28.9M | 1.95% |
2,745,000
+157,500
| +6% | +$1.64M |
|
|
NETD
13
DELISTED
Nabors Energy Transition Corp II
NETD
| $28.8M | 1.94% |
2,591,412
-3,588
| -0.1% | -$39.6K |
|
14
Palmer Square Capital BDC
PSBD
$296M
| $27.9M | 1.89% |
2,000,561
| – | – |
|
|
MRLN
15
Merlin Inc
MRLN
$335M
| $23.4M | 1.58% |
2,265,000
+1,000,000
| +79% | +$10.2M |
|
|
DMAA
16
Drugs Made In America Acquisition Corp
DMAA
$260M
| $22.9M | 1.55% |
2,242,500
+175,798
| +9% | +$1.78M |
|
|
HYAC
17
DELISTED
Haymaker Acquisition Corp 4
HYAC
| $22.8M | 1.54% |
2,055,853
| – | – |
|
|
CHYM
18
Chime Financial
CHYM
$7.88B
| $22.7M | 1.53% |
+656,598
| New | +$21.6M |
|
|
CUB
19
Lionheart Holdings
CUB
$283M
| $22.5M | 1.52% |
2,145,000
+75,000
| +4% | +$779K |
|
|
GRAF
20
Graf Global Corp
GRAF
$153M
| $22.4M | 1.51% |
2,139,248
+65,332
| +3% | +$676K |
|
|
GPAT
21
GP-Act III Acquisition Corp
GPAT
| $22.1M | 1.49% |
2,091,077
-496,423
| -19% | -$5.19M |
|
|
LPAA
22
Launch One Acquisition Corp
LPAA
| $21.6M | 1.46% |
2,070,000
| – | – |
|
|
LEGT
23
DELISTED
Legato Merger Corp III
LEGT
| $19.2M | 1.3% |
1,801,191
| – | – |
|
|
SIMA
24
SIM Acquisition Corp I
SIMA
| $18.8M | 1.27% |
1,800,000
| – | – |
|
|
VCIC
25
DELISTED
Vine Hill Capital Investment Corp
VCIC
| $18.7M | 1.27% |
1,799,998
+20,000
| +1% | +$206K |
|
Similar funds
RCA
IAN
DCP
BOH
EP
MC
RIL
SIC
First Trust Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, First Trust Capital Management held 149 positions worth $1.48B, up 6.9% from $1.38B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
First Trust Capital Management deployed $45M of net new capital in Q2 2025, opening 58 new positions and adding to 19 existing holdings. Its largest new stake was SpringWorks Therapeutics: 1,943,767 shares worth $91.3M.
By sector, the portfolio is most concentrated in Financials at 60% of assets, up from 45% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $11.2M trimmed.
- First Trust Capital Management's largest Q2 2025 buy was SpringWorks Therapeutics: 1,943,767 shares worth $91.3M.
- First Trust Capital Management added most to Dun & Bradstreet in Q2 2025, an estimated $77.7M increase.
- First Trust Capital Management's biggest Q2 2025 reduction was Walgreens Boots Alliance, cutting an estimated $11.2M.
- First Trust Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $94.9M.
- First Trust Capital Management's ten largest holdings make up 43% of its $1.48B portfolio in Q2 2025.
- First Trust Capital Management opened 58 new positions and closed 28 in Q2 2025.
- First Trust Capital Management's portfolio value rose 6.9% quarter-over-quarter to $1.48B.
Based on First Trust Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.